1-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy--4-penylpiperidines, of formula:
wherein X is hydrogen, loweralkyl, loweralkoxy, halogen or trifluoromethyl; Y is hydrogen or trifluoromethyl with the proviso that Y is hydrogen when X is hydrogen, loweralkyl, loweralkoxy or trifluoromethyl and Y is hydrogen, trifluoromethyl when X is halogen; the optical antipodes thereof, or pharmaceutically acceptable addition salts thereof, processes and intermediates for the preparation thereof, a process for the preparation of the intermediate, and the use of the title compounds as medicaments are disclosed.
公开了1-[3-(6-
氟-1,2-苯并
异噁唑-3-基)丙基]-
4-羟基--
4-戊基哌啶,其式为: 其中X为氢、低级烷基、低级烷氧基、卤素或三
氟甲基;Y为氢或三
氟甲基,但条件是当X为氢、低级烷基、低级烷氧基或三
氟甲基时Y为氢,当X为卤素时Y为氢、三
氟甲基;其光学对映体或其药学上可接受的加成盐,其制备工艺和中间体,中间体的制备工艺,以及标题化合物作为药物的用途。